Proteinase-activated receptor 2 activation modulates guinea-pig mesenteric lymphatic vessel pacemaker potential and contractile activity

Journal of Physiology

Volumn 560, Issue 2, 2004, Pages 563-576

  Chan, Alice K ^a   Vergnolle, Nathalie ^a   Hollenberg, Morley D ^a   von der Weid, Pierre Yves ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLIBENCLAMIDE; GUANYLATE CYCLASE; ILOPROST; INDOMETACIN; NITRIC OXIDE SYNTHASE; PEPTIDE; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; PROTEINASE ACTIVATED RECEPTOR 2; TRYPSIN; MESSENGER RNA; SERYLLEUCYLISOLEUCYLGLYCYLARGINYLLEUCINAMIDE; UNCLASSIFIED DRUG;

ACTION POTENTIAL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEPOLARIZATION; EDEMA; ELECTRIC ACTIVITY; FEMALE; GUINEA PIG; HYPERPOLARIZATION; INFLAMMATION; INTERSTITIUM; ISOLATED ORGAN; LYMPH VESSEL; LYMPH VESSEL ENDOTHELIUM; MALE; MEMBRANE POTENTIAL; MICROELECTRODE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE; SMOOTH MUSCLE CONTRACTILITY; SMOOTH MUSCLE TONE; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION; ANIMAL EXPERIMENT; CELL MEMBRANE DEPOLARIZATION; ENZYME INHIBITION; GENE ACTIVATION; INTRACELLULAR RECORDING; LYMPHATIC PARAMETERS; LYMPHATIC VESSEL CONTRACTILE ACTIVITY; MESENTERIC LYMPHATIC VESSEL; METABOLITE; PACEMAKER; PAR2 GENE; PHARMACOLOGICAL BLOCKING; SMOOTH MUSCLE FIBER MEMBRANE POTENTIAL; SPONTANEOUS TRANSIENT DEPOLARIZATION;

ANIMALS; BIOLOGICAL CLOCKS; CYCLOOXYGENASE INHIBITORS; ENDOTHELIUM; ENZYME INHIBITORS; FEMALE; GLYBURIDE; GUINEA PIGS; LYMPHATIC VESSELS; MALE; MEMBRANE POTENTIALS; MESENTERY; MUSCLE, SMOOTH; NERVE ENDINGS; NITRIC OXIDE SYNTHASE; OLIGOPEPTIDES; PERFUSION; RECEPTOR, PAR-2; RNA, MESSENGER; TETRODOTOXIN; TRYPSIN;

EID: 7444231605     PISSN: 00223751     EISSN: None     Source Type: Journal    
DOI: 10.1113/jphysiol.2004.071399     Document Type: Article

References (49)

1. Al-Ani B, Saifeddine M & Hollenberg MD (1995). Detection of functional receptors for the proteinase-activated-receptor-2-activating polypeptide, SLIGRL-NH2, in rat vascular and gastric smooth muscle. Can J Physiol Pharmacol 73, 1203-1207.
2. Amadesi S, Nie J, Vergnolle N, Cottrell GS, Grady EF, Trevisani M, Manni C, Geppetti P, McRoberts JA, Ennes H, Davis JB, Mayer EA & Bunnett NW (2004). Protease-activated receptor 2 sensitizes the capsaicin receptor transient receptor potential vanilloid receptor 1 to induce hyperalgesia. J Neurosci 24, 4300-4312.
3. Benoit JN & Zawieja DC (1992). Effects of f-Met-Leu-Phe-induced inflammation on intestinal lymph flow and lymphatic pump behavior. Am J Physiol 262, G199-202.
4. Benoit JN, Zawieja DC, Goodman AH & Granger HJ (1989). Characterization of intact mesenteric lymphatic pump and its responsiveness to acute edemagenic stress. Am J Physiol 257, H2059-2069.
5. Bhattacharya A & Cohen ML (2000). Vascular contraction and relaxation to thrombin and trypsin: thrombomodulin preferentially attenuates thrombin-induced contraction. J Pharmacol Exp Ther 295, 284-290.
6. Cenac N, Coelho AM, Nguyen C, Compton S, Andrade-Gordon P, MacNaughton WK, Wallace JL, Hollenberg MD, Bunnett NW, Garcia-Villar R, Bueno L & Vergnolle N (2002). Induction of intestinal inflammation in mouse by activation of proteinase-activated receptor-2. Am J Pathol 161, 1903-1915.
7. Chan AK & von der Weid P-Y (2002). Effect of PAR-2 activation on guinea-pig mesenteric lymphatic vessels. Faseb J 16, A77.
8. Chan AK & von der Weid P-Y (2003). 5-HT decreases contractile and electrical activities in lymphatic vessels of the guinea-pig mesentery: role of 5-HT 7-receptors. Br J Pharmacol 139, 243-254.
9. Cicala C (2002). Protease activated receptor 2 and the cardiovascular system. Br J Pharmacol 135, 14-20.
10. Corvera CU, Dery O, McConalogue K, Gamp P, Thoma M, Al-Ani B, Caughey GH, Hollenberg MD & Bunnett NW (1999). Thrombin and mast cell tryptase regulate guinea-pig myenteric neurons through proteinase-activated receptors-1 and -2. J Physiol 517, 741-756.
11. Dery O, Corvera CU, Steinhoff M & Bunnett NW (1998). Proteinase-activated receptors: novel mechanisms of signaling by serine proteases. Am J Physiol 224, C1429-1452.
12. Emilsson K, Wahlestedt C, Sun MK, Nystedt S, Owman C & Sundelin J (1997). Vascular effects of proteinase-activated receptor 2 agonist peptide. J Vasc Res 34, 267-272.
13. Fox JL & von der Weid P-Y (2002). Effects of histamine on the contractile and electrical activity in isolated lymphatic vessels of the guinea-pig mesentery. Br J Pharmacol 136, 1210-1218.
14. Gao C, Liu S, Hu HZ, Gao N, Kim GY, Xia Y & Wood JD (2002). Serine proteases excite myenteric neurons through protease-activated receptors in guinea pig small intestine. Gastroenterology 123 1554-1564.
15. 2. Br J Pharmacol 127, 1597-1602.
16. Hamilton JR & Cocks TM (2000). Heterogeneous mechanisms of endothelium-dependent relaxation for thrombin and peptide activators of protease-activated receptor-1 in porcine isolated coronary artery. Br J Pharmacol 130, 181-188.
17. Hamilton JR, Frauman AG & Cocks TM (2001). Increased expression of protease-activated receptor-2 (PAR2) and PAR4 in human coronary artery by inflammatory stimuli unveils endothelium-dependent relaxations to PAR2 and PAR4 agonists. Circ Res 89, 92-98.
18. Hollenberg MD & Compton SJ (2002). International Union of Pharmacology. XXVIII. Proteinase-activated receptors. Pharmacol Rev 54, 203-217.
19. Johnston MG (1987). Interaction of inflammatory mediators with the lymphatic vessel. Pathol Immunopathol Res 6, 177-189.
20. Johnston MG & Feuer C (1983). Suppression of lymphatic vessel contractility with inhibitors of arachidonic acid metabolism. J Pharmacol Exp Ther 226, 603-607.
21. Johnston MG & Gordon JL (1981). Regulation of lymphatic contractility by arachidonate metabolites. Nature 293, 294-297.
22. Johnston MG, Kanalec A & Gordon JL (1983). Effects of arachidonic acid and its cyclo-oxygenase and lipoxygenase products on lymphatic vessel contractility in vitro. Prostaglandins 25, 85-98.
23. McGuire JJ, Hollenberg MD, Andrade GP & Triggle CR (2002). Multiple mechanisms of vascular smooth muscle relaxation by the activation of proteinase-activated receptor 2 in mouse mesenteric arterioles. Br J Pharmacol 135, 155-169.
24. McLean PG, Aston D, Sarkar D & Ahluwalia A (2002). Protease-activated receptor-2 activation causes EDHF-like coronary vasodilation: selective preservation in ischemia/reperfusion injury: involvement of lipoxygenase products, VR1 receptors, and C-fibers. Circ Res 90, 465-472.
25. Mizuno R, Koller A & Kaley G (1998). Regulation of the vasomotor activity of lymph microvessels by nitric oxide and prostaglandins. Am J Physiol 274, R790-796.
26. Moffatt JD & Cocks TM (1998). Endothelium-dependent and -independent responses to protease-activated receptor-2 (PAR-2) activation in mouse isolated renal arteries. Br J Pharmacol 125 591-594.
27. Nakayama T, Hirano K, Nishimura J, Takahashi S & Kanaide H (2001). Mechanism of trypsin-induced endothelium-dependent vasorelaxation in the porcine coronary artery. Br J Pharmacol 134, 815-826.
28. Narumiya S, Sugimoto Y & Ushikubi F (1999). Prostanoid receptors: structures, properties, and functions. Physiol Rev 79 1193-1226.
29. Ossovskaya VS & Bunnett NW (2004). Protease-activated receptors: contribution to physiology and disease. Physiol Rev 84, 579-621.
30. 2. Br J Pharmacol 121, 1589-1596.
31. Reed DE, Barajas-Lopez C, Cottrell G, Velazquez-Rocha S, Dery O, Grady EF, Bunnett NW & Vanner SJ (2003). Mast cell tryptase and proteinase-activated receptor 2 induce hyperexcitability of guinea-pig submucosal neurons. J Physiol 547, 531-542.
32. Robin J, Kharbanda R, Mclean P, Campbell R & Vallance P (2003). Protease-activated receptor 2-mediated vasodilatation in humans in vivo: role of nitric oxide and prostanoids. Circulation 107 954-959.
33. Roy SS, Saifeddine M, Loutzenhiser R, Triggle CR & Hollenberg MD (1998). Dual endothelium-dependent vascular activities of proteinase-activated receptor-2-activating peptides: evidence for receptor heterogeneity. Br J Pharmacol 123, 1434-1440.
34. Saifeddine M, Al-Ani B, Cheng CH, Wang L & Hollenberg MD (1996). Rat proteinase-activated receptor-2 (PAR-2): cDNA sequence and activity of receptor-derived peptides in gastric and vascular tissue. Br J Pharmacol 118, 521-530.
35. Sobey CG & Cocks TM (1998). Activation of protease-activated receptor-2 (PAR-2) elicits nitric oxide-dependent dilatation of the basilar artery in vivo. Stroke 29, 1439-1444.
36. Steinhoff M, Vergnolle N, Young SH, Tognetto M, Amadesi S, Ennes HS, Trevisani M, Hollenberg MD, Wallace JL, Caughey GH, Mitchell SE, Williams LM, Geppetti P, Mayer EA & Bunnett NW (2000). Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism. Nat Med 6, 151-158.
37. - current in sheep lymphatic smooth muscle. Am J Physiol 279, C1327-1335.
38. Trottier G, Hollenberg M, Wang X, Gui Y, Loutzenhiser K & Loutzenhiser R (2000). PAR-2 elicits afferent arteriolar vasodilation by NO-dependent and NO-independent actions. Am J Physiol 282, F891-897.
39. van Helden DF (1993). Pacemaker potentials in lymphatic smooth muscle of the guinea-pig mesentery. J Physiol 471, 465-479.
40. van Helden DF, von der Weid P-Y & Crowe MJ (1995). Electrophysiology of lymphatic smooth muscle. In Interstitium, Connective Tissue, and Lymphatics, ed. Bert J, Laine GA, McHale NG, Reed R & Winlove P, pp. 221-236. Portland Press, London.
41. 2+ release: a basis for electrical pacemaking in lymphatic smooth muscle. In Smooth Muscle Excitation, ed. Tomita T & Bolton TB, pp. 355-373. Academic Press, London.
42. Vergnolle N, Hollenberg MD, Sharkey KA & Wallace JL (1999). Characterization of the inflammatory response to proteinase-activated receptor-2 (PAR2) -activating peptides in the rat paw. Br J Pharmacol 127, 1083-1090.
43. Vergnolle N, Wallace JL, Bunnett NW & Hollenberg MD (2001). Protease-activated receptors in inflammation, neuronal signaling and pain. Trends Pharmacol Sci 22, 146-152.
44. + channels in smooth muscle cells of guinea-pig mesenteric lymphatics: role in nitric oxide and beta-adrenoceptor agonist-induced hyperpolarizations. Br J Pharmacol 125, 17-22.
45. von der Weid P-Y (2001). Lymphatic vessel pumping and inflammation - the role of spontaneous constrictions and underlying electrical pacemaker potentials. Aliment Pharmacol Ther 15, 1115-1129.
46. von der Weid P-Y & Chan AK (2004). PAR-2 activation depresses spontaneous lymphatic vessel pumping via the release of endothelium-derived prostanoids. Memorias Do Instituto Oswaldo Cruz (in press).
47. von der Weid PY, Crowe MJ & van Heiden DF (1996). Endothelium-dependent modulation of pacemaking in lymphatic vessels of the guinea-pig mesentery. J Physiol 493, 563-575.
48. von der Weid P-Y, Zhao J & van Helden DF (2001). Nitric oxide decreases pacemaker activity in lymphatic vessels of guinea pig mesentery. Am J Physiol 280, H2707-2716.
49. Vu TK, Hung DT, Wheaton VI & Coughlin SR (1991). Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 64, 1057-1068.